National Institute of Mental Health (NIMH)
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, National Institute of Mental Health (NIMH) sits in the top decile of US sponsors by registered trial count (#103 of 15,742 sponsors by registered trial count).
National Institute of Mental Health (NIMH): 343 sponsored US clinical trials, 42 recruiting.
National Institute of Mental Health (NIMH) sponsors 343 registered US clinical trials on ClinicalTrials.gov, 42 of them currently recruiting, and 256 completed. 29 of these trials are in Phase 3-4 (later-stage) and 106 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 21 trials.
Top-decile sponsor footprint
National Institute of Mental Health (NIMH) ranks in the top decile of sponsors by registered trial count (#103 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
256 of 296 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
343 total, page 3 of 7
Oxytocin and Arginine Vasopressin in Pain Relief
NCT01328561
A Study of the Association Between Autism and Immune Changes in the Brain
NCT01322555
Intravenous Immunoglobulin for PANDAS
NCT01281969
PET Brain and Whole Body Distribution Studies for Nociceptin/Orphanin FQ Peptide (NOP) Receptor Using [11C]NOP-1A
NCT01198197
An Exploratory Study of the Characteristics of and Challenges for International Families Seeking Medical Care in the United States
NCT01211990
PET Whole Body Distribution Studies Using [11C]CUMI
NCT01132872
Cognitive Neuroscience of Autism Spectrum Disorders
NCT01031407
Brain Imaging Study of Adults With Autism Spectrum Disorders
NCT01093768
Imaging Cannabinoid CB1 Receptors in Schizophrenia
NCT01063335
Effects of a CRF1 Receptor Antagonist on Human Startle in Normal Female Volunteers
NCT01059227
A Magnetic Resonance Spectroscopic Examination of Children and Adolescents Taking Riluzole for Obsessive-Compulsive Disorder
NCT01019967
Functional Relevance of Dopamine Receptors in Healthy Controls and Patients With Schizophrenia: Characterization Through [11C]NNC-112 and [18F]Fallypride Positron Emission Tomography
NCT00942981
Characterizing Lone Parenting: A Multi-institutional Pilot Study of the Perceptions of Support and Perceived Stress of Lone Parents of Children With Cancer
NCT00969579
Screening and Evaluation of Patients With Signs and Symptoms of Alzheimer's Disease
NCT00955422
Feasibility of Providing Cognitive Remediation to People With Schizophrenia in a Clinical Network
NCT00930150
CO2 Inhalation and Risk for Panic Disorder
NCT00930657
Identification of Characteristics Associated With Symptom Remission in Autism
NCT00938054
Regional Rates of Cerebral Protein Synthesis: Effects of Sleep and Memory Consolidation
NCT00884702
Development and Decline of Brain and Cognition Through the Life Span
NCT00880451
The Use of a Distress Thermometer in a Pediatric Research Setting: An Exploratory Pilot Study
NCT00824278
The Use of Metformin in the Treatment of Antipsychotic-Induced Weight Gain in Schizophrenia (The METS Study)
NCT00816907
Imaging Cannabinoid CB1 Receptors in Alcohol Dependence
NCT00816439
Comparison of Optimal Antipsychotic Treatments for Adults With Schizophrenia
NCT00802100
A Controlled Trial of Serotonin Reuptake Inhibitors Added to Stimulant Medication in Youth With Severe Mood Dysregulation
NCT00794040
Double-Blind Placebo-Controlled Trial of Riluzole in Pediatric Bipolar Disorder
NCT00805493
Transcranial Direct Current Brain Stimulation to Treat Patients With Childhood-Onset Schizophrenia
NCT00757497
PET Imaging of Peripheral Benzodiazepine Receptors
NCT00696371
p11 Protein Levels in Patients With Major Depressive Disorder Treated With Citalopram
NCT00697268
The Effect of Donepezil (Aricept(Registered Trademark)) on REM Sleep in Children With Autism
NCT00695136
P-glycoprotein Function in Brain Diseases
NCT00677885
Effectiveness of Lithium Plus Optimized Medication in Treating People With Bipolar Disorder
NCT00667745
Mirror Therapy for Phantom Limb Pain
NCT00623818
Combining Medications to Enhance Depression Outcomes
NCT00590863
Detecting Risk of Suicide in a Pediatric Emergency Department
NCT00623493
PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in Frontotemporal Dementia
NCT00613119
PET Imaging of P-glycoprotein Function Using [11C]dLop
NCT00605254
PET Imaging of Cannabinoid CB1 Receptors Using [11C]MePPEP
NCT00598390
PET Imaging of Cannabinoid CB1 Receptors Using [18F]FMPEP-d2
NCT00598286
PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Carotid Atherosclerosis
NCT00547976
The Effects of Atomoxetine on Cognition and Brain Function Based on Catechol-O-methyltransferase(COMT) Genotype
NCT00548327
PET Imaging of Brain mGluR5 Receptors Using [18F]SP203
NCT00538798
PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [F-18]FB
NCT00527579
PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [C-11]PBR28
NCT00526916
Assessing Treatment Emergent Suicidal Ideation in Patients With Major Depression
NCT00532103
Antidepressant Effects of NR2B in Major Depression
NCT00472576
PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in HIV-Seropositive Patients With (MCMD)
NCT00459693
Functional Neuroanatomy of Emotion Perception, Recognition, Learning, and Memory
NCT00458432
Imaging of Cannabinoid Receptors Using New Radioactive Tracer
NCT00450021
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
NCT00423878
PET Imaging of Brain Amyloid Using [11C]MeS-IMPY
NCT00407576
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 61 |
| Phase 2 | 45 |
| Phase 3 | 8 |
| Phase 4 | 21 |
Therapeutic Areas
What is open in the National Institute of Mental Health (NIMH) pipeline
42 recruiting of 343 indexed (12% open); 256 completed (75%).
Phase mix: 29 late (III/IV) vs 106 early (I/II) (early-phase heavy).
Top condition: Healthy (21 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
National Institute of Mental Health (NIMH): open-pipeline peers nationwide
Peers matched on 343 registered trials and 12% open enrollment, not the therapeutic-area sidebar.
National Institute of Mental Health (NIMH) sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 343 trials (± recruiting share)
- Children's Oncology Group · 342 trials · 10% recruiting
- Montefiore Medical Center · 345 trials · 19% recruiting
- Ohio State University Comprehensive Cancer Center · 341 trials · 23% recruiting
- Cedars-Sinai Medical Center · 339 trials · 21% recruiting
Sponsors near 12% open enrollment (± trial volume)
- Augusta University · 12% recruiting · 106 trials
- University of Iowa · 12% recruiting · 228 trials
- Daiichi Sankyo · 12% recruiting · 236 trials
- Friends Research Institute · 12% recruiting · 41 trials
Related
What to do with this National Institute of Mental Health (NIMH) page
343 registered trials is a research-attention snapshot, not an endorsement of National Institute of Mental Health (NIMH) or any single study.
- 42 of National Institute of Mental Health (NIMH)'s trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Healthy is the condition National Institute of Mental Health (NIMH) studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
National Institute of Mental Health (NIMH) pipeline card: 343 registered trials from official public datasets.Report a data error.